| Name
|
Neuropeptide Y (13-36), Human
|
| Other Name
|
NPY 13-36
|
| Sequence (Single letter abbreviations)
|
PAEDMARYYSALRHYINLITRQRYNH2
|
| Sequence（Three letter abbreviations）
|
{PRO}{ALA}{GLU}{ASP}{MET}{ALA}{ARG}{TYR}{TYR}{SER}{ALA}{LEU}{ARG}{HIS}{TYR}{ILE}{ASN}{LEU}{ILE}{THR}{ARG}{GLN}{ARG}{TYR}-NH2
|
| C-port
|
NH2
|
| Basic description
|
The C-terminal NPY fragment (13-36) [NPY-(13-36)], a Y2 receptor agonist, elicits vasopressor responses upon central administration. The cardiovascular responses of NPY-(13-36), together with the distribution of NPY receptor subtypes within the nucleus tractus solitarius (nTS), have been studied in spontaneously hypertensive rats (SHR). Neuropeptide Y (13-36) (NPY 13-36) stimulates both Y2 and Y5 NPY receptor subtypes, but causes no increase in food intake even when injected at doses, while the full-length NPY is one of the more potent physiological stimulants of feeding yet described. NPY 13-16 inhibits retinotectal transfer in amphibians.
|
| The molecular weight
|
3000.410
|
| Chemical formula
|
C134H207N41O36S1
|
| The purity
|
> 95%
|
| Storage conditions
|
Store the peptide at -20°C.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Amlal H, et al. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Cancer Res. Apr 2006; 66(7): 3706-3714.
Murdock RC., etc. Optimization of a Paper-Based ELISA for a Human Performance Biomarker. Anal Chem. 2013 Nov;85(23):11634-42.
|
Neuropeptide Y (13-36), Human
